Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

Added 285 days ago (08.12.2020)
Authors: Pauline Wils, Philippe Seksik, Carmen Stefanescu, Stephane Nancey, Matthieu Allez, Guillaume Pineton de Chambrun, Romain Altwegg, Cyrielle Gilletta, Lucine Vuitton, Stéphanie Viennot, Mélanie Serrero, Mathurin Fumery, Guillaume Savoye, Michael Collins, Felix Goutorbe, Hedia Brixi, Guillaume Bouguen, Noémie Tavernier, Medina Boualit, Aurélien Amiot, Vered Abitbol, David Laharie, Benjamin Pariente, on behalf of the PREGNANCY‐AID study group, Benjamin Pariente, Maria Nachury, Pauline Wils, Pierre Desreumaux, Julien Branche, Romain Gérard, Philippe Seksik, Anne Bourrier, Laurent Beaugerie, Harry Sokol, Julien Kirchgesner, Carmen Stefanescu, Yoram Bouhnik, Xavier Treton, Stephane Nancey, Gilles Boschetti, Bernard Flourié,Claire Gay, Pauline Danion, Chloe Venturin, Matthieu Allez, Jean‐Marc Gornet, Clotilde Baudry, Guillaume Pineton de Chambrun, Romain Altwegg, Cyrielle Gilletta, Lucine Vuitton, Stephanie Viennot, Melanie Serrero, Jean Charles Grimaud, Mathurin Fumery, Franck Brazier, Clara Yzet, Michael Collins, Félix Goutorbe, Hedia Brixi, Guillaume Cadiot, Guillaume Bouguen, Noémie Tavernier, Médina Boualit, Aurélien Amiot, Charlotte Gagnière, Jenny Tannoury, Vered Abitbol, David Laharie, Pauline Rivière, Florian Poullenot
Read article